Belgium developing new class of antibiotics, but incentives and market support needed

EURACTIV - Europe's pipeline of new antibiotics to tackle the growing antimicrobial resistance (AMR) crisis remains inadequate. Belgium is developing a new antibiotic class, but success depends on securing vital support and incentives. Read more

"For more than two decades, the AMR field has been steadily losing vital scientific and research talent."